FDA Inspection
Billings Clinic Innovative FertilityBillings Clinic Innovative Fertility – FDA Inspection, Jul 14, 2023
Record Details
This FDA Inspection record concerns Billings Clinic Innovative Fertility, with an inspection on July 14, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 8d8def47-0d92-4e5e-8329-ab8e0e6144e2
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1210082
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 1271.75(a)(1)Risk factors, clinical evidence
- 21 CFR 1271.75(a)(1)Risk factors, clinical evidence
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Billings Clinic Innovative Fertility
3| Date | Classification | Office | Project area |
|---|---|---|---|
| July 22, 2025 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 9, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 18, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Billings Clinic Innovative Fertility
- FDA Inspection 1278180 - 2025-07-22
- FDA Inspection 1011505 - 2017-05-09
- FDA Inspection 933696 - 2015-06-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.